You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. SBIR Phase I: Large Aperture, Periodically Poled, Hydrothermal Potassium Titanyl Phosphate for Highly Efficient Frequency Conversion of High-Power Solid-State and Fiber Lasers.

    SBC: ADVR, INC.            Topic: N/A

    This Small Business Innovation Research (SBIR) Phase I project proposes to investigate the feasibility of fabricating large-aperture, periodic ferroelectric domain gratings for quasi-phase matched laser frequency conversion. The key innovation in this effort is the use of low temperature hydrothermally grown potassium titanyl phosphate (LTH-KTP) as the nonlinear optical substrate material. Using L ...

    SBIR Phase I 2003 National Science Foundation
  2. Aging Resistant Ceramics for Total Hip Arthroplasty

    SBC: SINTX TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Zirconia bio-ceramics (e.g. Prozyr) have the highest toughness and strength compared to other bio-ceramics such as alumina (e.g. Biolox) or zirconia-toughened alumina (Biolox-Delta). However, as highlighted by the recent recall of St. Gobain zirconia heads, a critical need remains to develop bio-ceramics with both significantly reduced wear characteristics and ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  3. Ultraviolet Light Devices for Vitamin D

    SBC: APOLLO LIGHT SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Vitamin D deficiency is now recognized as a significant health problem for middle-aged and older adults. Vitamin D deficiency exacerbates osteoporosis and causes the bone disease, osteomalacia. Vitamin D deficiency increases risk of skeletal fractures. It is well known that the ultraviolet B portion of the solar spectrum is responsible for the cutaneous product ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  4. Site Directed Thrombolytic Agent

    SBC: AURAZYME PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Clot formation and dissolution are essential to human survival. Abnormal clot formation and occlusion of blood vessels of the heart, lung, brain, and peripheral circulation can result in death, incapacitation, and limb amputation. Rapid treatment with thrombolytic agents to dissolve clots and restore blood flow is a means to minimize morbidity and mortality i ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  5. Ovalbumin locus BACs for expression of biotherapeutics

    SBC: AviGenics Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): With a daily production capacity of two grams of protein per egg, the chicken ovalbumin gene locus has the potential to synthesize large amounts of biopharmaceutical proteins into the eggs of transgenic hens. This phase I SBIR project will test the feasibility of using large expression constructs, based on the complete 200 kilobase chicken ovalbumin gene locus, ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  6. Casein Coated CAP Particles for Oral Insulin Delivery

    SBC: BIOSANTE PHARMACEUTICALS, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Parenteral administration of insulin via the subcutaneous route is the only commercially available therapy to treat insulin-dependent diabetes mellitus. Multiple daily injections are required to manage and maintain blood glucose control due to its relatively short duration of action (4 to 8 hours). Oral insulin would provide an attractive alternative. However, ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  7. SBIR Phase II: Green Solvent Mixtures as Alternatives to Environmentally Damaging and Toxic Solvents

    SBC: CCVD, Inc dba MicroCoating Technologies (MCT)            Topic: N/A

    This SBIR Phase II Project will develop software to aid formulation chemists in the replacement of environmentally damaging and toxic solvents such as those listed as hazardous air pollutants (HAP) in Section 112(b)(1) of the Clean Air Act. Phase I provided successful proof of concept for MCT's approach to use mixtures of "green" solvents that are tunable to obtain a wide range of solvent characte ...

    SBIR Phase I 2003 National Science Foundation
  8. SBIR Phase II: Green Solvent Mixtures as Alternatives to Environmentally Damaging and Toxic Solvents

    SBC: CCVD, Inc dba MicroCoating Technologies (MCT)            Topic: N/A

    This SBIR Phase II Project will develop software to aid formulation chemists in the replacement of environmentally damaging and toxic solvents such as those listed as hazardous air pollutants (HAP) in Section 112(b)(1) of the Clean Air Act. Phase I provided successful proof of concept for MCT's approach to use mixtures of "green" solvents that are tunable to obtain a wide range of solvent characte ...

    SBIR Phase II 2003 National Science Foundation
  9. SBIR Phase I: Metal Nanoclusters Embedded Composite Thin Films for Photonic Applications

    SBC: CCVD, Inc dba MicroCoating Technologies (MCT)            Topic: N/A

    This Small Business Innovation Research (SBIR) Phase I project will develop a novel approach to synthesizing nanocluster embedded dielectric thin films for photonics applications. Nanosized particles embedded dielectric matrices have shown unique physical, chemical, optical, electronic, catalytic, and magnetic properties. For nonlinear optical (NLO) applications, the intrinsic properties of the ...

    SBIR Phase I 2003 National Science Foundation
  10. SBIR Phase I: Novel Sample Introduction Technique for ICP-MS/AES using a NanomiserTM Device for Spray Formation

    SBC: CCVD, Inc dba MicroCoating Technologies (MCT)            Topic: N/A

    This Small Business Innovation Research Phase I project will develop a method to lower the practical quantitation level of arsenic using a novel instrumental improvement to existing Inductively Coupled Plasma - Mass Spectrometry (ICP-MS) and Atomic Emission Spectrometry (AES) techniques. by replacing the standard sample introduction nebulizer and spray chamber used in ICP-MS and ICP-AES with the N ...

    SBIR Phase I 2003 National Science Foundation
US Flag An Official Website of the United States Government